Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain((R)) Line Probe Assay in Southern provinces, Zimbabwe

Timire, C., Sandy, C., Kumar, A. M., Ngwenya, M., Murwira, B., Takarinda, K. C. and Harries, A. D.

OBJECTIVES: To determine the proportion of rifampicin-resistant tuberculosis (RR-TB) patients who accessed second-line drug susceptibility testing (SL-DST) results following introduction of the Hain technology in southern provinces, Zimbabwe.

DESIGN: Cohort study using secondary data.

RESULTS: Xpert MTB/RIF results were used to identify 133 RR-TB patients for this study. Their mean age (SD) was 37.9 (11.1) years, 83(62%) were males and 106 (80%) were HIV-infected. There were 6 (5%) participants who had pre-treatment attrition. Of the 133 pulmonary TB (PTB) patients, 117(80%) had additional sputum specimens collected; 96(72%) specimens reached the National TB Reference Laboratory (NTBRL); 95(71%) were processed; 68(51%) had SL-DST results. Only 53(40%) SL-DST results reached the peripheral facilities. Median time from specimen collection to reception at the NTBRL to SL-DSTs was 40 days, interquartile range (IQR:28-67). Median time from presumptive diagnosis of RR-TB by health care worker to SL-DST results was 50days (IQR:39-80), and increased to 79days (IQR:39-101) in facilities >250km from the NTBRL. The proportion with any fluoroquinolone resistance was 9(13.2%).

CONCLUSION: Although RR-TB patients with PTB were initiated timely on treatment, access to SL-DSTs by facilities needs improvement. Health inequities exist as remote areas are less likely to get SL-DST results in time.

April 12, 2019
Year of publication
Resource types
Journal and research articles
rifampicin-resistant tuberculosis (RR-TB), drug susceptibility testing (DST), Hain technology, pulmonary tuberculosis, drug resistance

Similar Resources

Despite successful treatment, retreatment TB survivors retain a substantial risk of morbidity and mortality.

To understand the uptake of HIV services by adolescent women, the authors conducted a retrospective analysis of patient-level data (2011–2013) on services for antenatal care (ANC) and prevention of mother-to-child transmission (PMTCT) in 36 facilities in 5 districts in Zimbabwe.

Female sex workers (FSW) in sub-Saharan Africa have a higher prevalence of HIV than other women of reproductive age. Social, legal, and structural barriers influence their access to care. Little is known about the HIV diagnosis and care cascade in most countries in southern Africa.

In view of expanding 'test and treat' initiatives, we sought to elicit how the experience of HIV testing influenced subsequent engagement in HIV care among people diagnosed with HIV.

Rapid diagnostic tests (RDT) for HIV infection have high sensitivity and specificity, but in the setting of longstanding antiretroviral therapy (ART), can give false results that can lead to misinterpretation, confusion and inadequate management.

This multi-country trial examined outcomes among treatment-naïve adults and children with CD4 counts below 100 who were given enhanced antimicrobial prophylaxis including trimethoprim-sulfamethoxazole, isoniazid-pyridoxine, fluconazole, azithromycin, and albendazole in addition to antiretroviral…

In most developing economies particularly in Africa, more people are likely to die of HIV/AIDS and malaria compared to other diseases. HIV/AIDS tends to be superimposed on the long standing malaria burden particularly in sub-Saharan Africa. The detection and understanding of spatial overlaps in…
The aim of the study was to investigate the extent of and factors associated with incorrect dosing of antiretroviral therapy (ART) in HIV-infected children in Harare, Zimbabwe.

BACKGROUND: WHO recommends that HIV infected women receive antiretroviral therapy (ART) minimally during pregnancy and breastfeeding ("Option B"), or ideally throughout their lives regardless of clinical stage ("Option B+") (Coovadia et al., Lancet 379:221-228, 2012).